CXCR4 and Miyoshi myopathy: Our study also revealed that the expression of BTK and CXCR4 is intratumorally heterogeneous in clinical MM samples from focal lesions and interstitial marrow of the myelomatous bone, suggesting that BTK is involved in determining proliferative, quiescent or metastatic phenotypes of MM cells (Figure 6c).